Citation Impact
Citing Papers
Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers
2016
Psychological therapies for the management of chronic pain (excluding headache) in adults
2012 Standout
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis
2010
Inflammation and Alzheimer's disease
2000 Standout
The economics of treatment in early rheumatoid arthritis
2009
Systematic review of involving patients in the planning and development of health care
2002 Standout
What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?
2001
A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective
2016
Large-scale gene function analysis with the PANTHER classification system
2013 Standout
Rheumatoid arthritis
2018 Standout
Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs
2010 Standout
A blind, randomized, controlled trial of cognitive-behavioural intervention for patients with recent onset rheumatoid arthritis: preventing psychological and physical morbidity
2001
Rheumatoid arthritis
2016 Standout
Very early treatment with infliximab in addition to methotrexate in early, poor‐prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve‐month randomized, double‐blind, placebo‐controlled trial
2005
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis
2006
When does rheumatoid arthritis begin and why do we need to know?
2000
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Extra-articular manifestations and complications of rheumatoid arthritis
2007
Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine
2010 Standout
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
Guillain-Barré syndrome
2016 Standout
Indole based peptidomimetics as anti-inflammatory and anti-hyperalgesic agents: Dual inhibition of 5-LOX and COX-2 enzymes
2015
Curcumin as “Curecumin”: From kitchen to clinic
2007 Standout
Anti-inflammatory Plant Flavonoids and Cellular Action Mechanisms
2004 Standout
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
Enantioselective rhodium-catalyzed addition of arylboronic acids to trifluoromethyl ketones
2006 StandoutNobel
Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
2013
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
2006
COX-2 Selective Nonsteroidal Anti-Inflammatory Drugs
2000
Topical Nonsteroidal Anti-Inflammatory Drugs for Ophthalmic Use
2002
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX
2008
Ageing and infection
2002 Standout
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis
2018
Cost-Effectiveness of Sequential Therapy with Tumor Necrosis Factor Antagonists in Early Rheumatoid Arthritis
2008
Patient Self-management of Chronic Disease in Primary Care
2002 Standout
Gene expression profiling in autoantibody‐positive patients with arthralgia predicts development of arthritis
2010
C-reactive protein: a valuable marker of sepsis
2002
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Newer Biological Agents in Rheumatoid Arthritis
2010
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
2020 StandoutNobel
Enteric viruses in the aquatic environment
2001
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Immediate access rheumatology clinic: efficiency and outcomes
2011
Rheumatoid arthritis
2010 Standout
Review of Eight Pharmacoeconomic Studies of the Value of Biologic DMARDs Adalimumab, Etanercept, and Infliximab) in the Management of Rheumatoid Arthritis
2006
A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice
2011 StandoutNobel
Hypertension in rheumatoid arthritis
2008
Arthritis and bone loss
2013
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
The Human Plasma Proteome
2002 Standout
The long-term outcomes from a randomized controlled trial of an educational–behavioural joint protection programme for people with rheumatoid arthritis
2004
Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review
2010
A Blind Randomized Controlled Trial of Cognitive versus Behavioral versus Cognitive-Behavioral Therapy for Patients with Rheumatoid Arthritis
2012
Beyond the dmft
2009 Standout
Analysis of changes in acute‐phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two‐dimensional gel electrophoresis
1998
COX-2 inhibitors
1999 Standout
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Health economic issues in rheumatoid arthritis
2006
Application of deep learning technique to manage COVID-19 in routine clinical practice using CT images: Results of 10 convolutional neural networks
2020 Standout
The burden of rheumatoid arthritis and access to treatment: health burden and costs
2007
The course of established rheumatoid arthritis
2007
Declines in Erythrocyte Sedimentation Rates in Patients with Rheumatoid Arthritis Over the Second Half of the 20th Century
2009
New cyclooxygenase‐2 inhibitors for treatment of experimental autoimmune neuritis
2002
Cyclo-Oxygenase-2 Inhibitors
2000
SARS-CoV-2 in wastewater: State of the knowledge and research needs
2020 Standout
Patient participation in service improvement: the initial Measures Project experience
1999
A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis
2012 Standout
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Nintedanib reduces pulmonary fibrosis in a model of rheumatoid arthritis-associated interstitial lung disease
2018
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Interventions for enhancing medication adherence
2014 Standout
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction
2011 Standout
Diagnosis and management of rheumatoid arthritis
2017
Konzentration des C-reaktiven Proteins (CRP) im Blutserum bei Hunden mit postoperativen Wundheilungsstörungen
2009
Mortality in rheumatoid arthritis: 2008 update.
2009
Brief Report: Testosterone Is Protective in the Sexually Dimorphic Development of Arthritis and Lung Disease in SKG Mice
2013 StandoutNobel
Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis
2010
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of J Devlin being referenced
Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: Results of eighteen years of followup from the early rheumatoid arthritis study
2007
Illness in a community associated with an episode of water contamination with sewage
1995
Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort
2010
How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow‐up in 732 patients from the Early RA Study (ERAS)
2000
Granisetron (Kytril) suppresses methotrexate-induced nausea and vomiting among patients with inflammatory arthritis and is superior to prochlorperazine (Stemetil)
1999
The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome.
1997
Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome
2005